Algert Global LLC Makes New $1.99 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Algert Global LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,046 shares of the medical equipment provider’s stock, valued at approximately $1,988,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical during the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC purchased a new position in Intuitive Surgical in the 1st quarter valued at $30,000. LGT Financial Advisors LLC increased its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the period. Finally, MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Wells Fargo & Company raised their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Trading Down 0.7 %

NASDAQ:ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00. The firm has a market cap of $191.82 billion, a price-to-earnings ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The company’s 50-day moving average is $507.94 and its two-hundred day moving average is $466.79.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 50,459 shares of company stock worth $26,080,251. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.